For most people, marijuana does not appear to be harmful to the liver, and some evidence suggests it may even offer modest protection against fatty liver disease. The picture is more nuanced than a simple yes or no, though. How much you use, what form you use, and whether you already have liver disease all shape the answer.
What Happens in Your Liver When You Use Cannabis
Your liver contains two types of receptors that respond to cannabinoids, and they do opposite things. One type promotes scarring and inflammation in liver tissue, while the other actually works against scarring by reducing the buildup of cells that drive it. THC and other cannabinoids activate both receptor types simultaneously, which is part of why the research can seem contradictory. The net effect depends on the balance between these two signals, which varies based on the dose, the specific cannabinoids involved, and the health of your liver to begin with.
Cannabis and Fatty Liver Disease
Fatty liver disease is the most common liver condition worldwide, driven largely by obesity and metabolic factors. A 2025 meta-analysis pooling nine studies found that cannabis users were about 42% less likely to have fatty liver compared to nonusers. Current users showed the clearest benefit, and light users (less than four days per week) had even stronger protective associations. Cannabis users in the pooled data also had a BMI roughly 1.9 points lower on average, which likely explains at least part of the effect.
Heavy users, defined as four or more days per week, did not show a statistically significant reduction in fatty liver risk. That doesn’t mean heavy use causes harm; the data was simply too inconsistent to draw a firm conclusion for that group. Importantly, while cannabis users scored better on a clinical index used to estimate fatty liver, their actual liver enzyme levels and triglycerides were not significantly different from nonusers. So the protective signal may be more about body composition than a direct liver benefit.
Cannabis and Hepatitis C
This is where earlier concerns originated. Some cross-sectional studies in patients with chronic hepatitis C suggested that cannabis use was linked to faster liver scarring. But when researchers conducted a systematic review and meta-analysis that included larger and better-designed studies, the association disappeared. The pooled data showed no increased prevalence of liver fibrosis among cannabis users with hepatitis C, and no increased rate of fibrosis progression in patients coinfected with both hepatitis C and HIV.
The early studies that raised red flags were retrospective and relatively small. The broader evidence now suggests that marijuana does not meaningfully accelerate liver damage in people with viral hepatitis.
What About Liver Cancer?
Marijuana has not been identified as a direct risk factor for liver cancer. While its role in liver scarring progression has been debated, prospective studies and meta-analyses have generally not supported a connection. Unlike cigarette smoking and anabolic steroids, which are well-established contributors to liver cancer, cannabis does not have an established link to liver tumor development.
CBD and Liver Enzymes
This is one area where there is a genuine, documented risk, though it applies specifically to high-dose CBD products rather than whole-plant marijuana. In a clinical trial of 201 healthy adults, 5.6% of those taking CBD developed liver enzyme elevations more than three times the normal upper limit, compared to 0% in the placebo group. A separate study using 300 mg of CBD daily for four weeks saw a similar rate of about 6.8%, with two participants meeting criteria for drug-induced liver injury.
A large observational study of long-term oral CBD users found that 9.1% had elevated levels of ALT (a key liver enzyme), but that rate was virtually identical to the 8.9% seen in the general adult population. The vast majority of those elevations were mild, with only 0.3% reaching levels three times the upper limit of normal.
The takeaway: standard CBD supplements at typical consumer doses are unlikely to cause liver problems for most people, but concentrated pharmaceutical-grade CBD at high doses (300 mg per day and above) can stress the liver. If you take CBD regularly, especially at higher doses, periodic liver function tests are reasonable.
Synthetic Cannabinoids Are a Different Story
Products sold as Spice or K2 are not marijuana. They contain lab-made chemicals that activate the same brain receptors as THC but with far greater potency, and they carry real risks of acute liver injury. Case reports document sudden liver damage in people using these products. The chemicals in synthetic cannabinoids behave fundamentally differently from natural THC, so any reassuring data about marijuana does not extend to synthetics.
Cannabis and Liver Transplants
If you have advanced liver disease and are considering or awaiting a transplant, cannabis use is worth discussing with your transplant team. Most transplant centers set their own policies on cannabis, and a positive THC test is not automatically disqualifying. At institutions where it has been studied, patients are typically counseled to switch from smoking to edible forms rather than to stop entirely. Recent research has concluded that strict avoidance of all cannabis products before transplant may be unnecessary, particularly when patients find them helpful for managing symptoms like nausea, pain, or poor appetite related to liver disease.
That said, policies vary widely between centers, and some programs still treat active cannabis use as a concern during the evaluation process. Transparency with your medical team is the practical move here.
The Bottom Line on Marijuana and Your Liver
Natural cannabis, whether smoked or consumed as edibles, does not appear to cause liver damage in otherwise healthy people. The pooled research actually tilts slightly in the protective direction for fatty liver disease, and the earlier concerns about hepatitis C progression have not held up under broader analysis. The main liver-related caution applies to high-dose CBD supplements and to synthetic cannabinoids, which are genuinely hepatotoxic. If you have existing liver disease, marijuana is not likely to make it worse, but it is also not a treatment for it.